Identifying early signs of pancreatic cancer using blood tests and imaging techniques
Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer
['FUNDING_U01'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-10864325
This study is looking for new ways to spot pancreatic cancer early by checking certain markers in the blood and using advanced scans, especially for people who might be at higher risk due to their family history, even if they don’t have any symptoms yet.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-10864325 on ClinicalTrials.gov |
What this research studies
This research focuses on finding early detection methods for pancreatic cancer by analyzing specific biomarkers in the blood and using advanced imaging techniques like CT and MRI scans. The study aims to develop predictive models that combine these biomarkers with imaging data to identify patients at high risk for pancreatic cancer, particularly those who are asymptomatic but have genetic or familial predispositions. By integrating various data types, the research seeks to create a comprehensive approach for early diagnosis and risk assessment of pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are asymptomatic individuals with a high risk of pancreatic cancer due to clinical, genetic, or familial factors.
Not a fit: Patients who do not have a familial or genetic predisposition to pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of pancreatic cancer, improving treatment outcomes for patients.
How similar studies have performed: Previous research has shown promise in using biomarker signatures and imaging for cancer detection, indicating that this approach could be effective.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SEN, SUBRATA — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: SEN, SUBRATA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.